Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacotherapy for amphetamine dependence: A systematic review
Nicole K. Lee, Linda Jenner, Angela Harney, et al.
Drug and Alcohol Dependence (2018) Vol. 191, pp. 309-337
Closed Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder
Martin P. Paulus, Jennifer L. Stewart
JAMA Psychiatry (2020) Vol. 77, Iss. 9, pp. 959-959
Open Access | Times Cited: 202
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Mette Kruse Klausen, Morgane Thomsen, Gitta Wörtwein, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 625-641
Open Access | Times Cited: 106
Non-pharmacological interventions for methamphetamine use disorder: a systematic review
P. V. Asharani, Aditi Hombali, Esmond Seow, et al.
Drug and Alcohol Dependence (2020) Vol. 212, pp. 108060-108060
Open Access | Times Cited: 101
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder

Journal of Addiction Medicine (2024) Vol. 18, Iss. 1S, pp. 1-56
Closed Access | Times Cited: 13
Methamphetamine and sleep impairments: neurobehavioral correlates and molecular mechanisms
Monika Vrajová, Romana Šlamberová, Cyril Höschl, et al.
SLEEP (2021) Vol. 44, Iss. 6
Open Access | Times Cited: 34
A systematic literature review of clinical trials and therapeutic applications of ibogaine
Patrick Köck, Katharina Froelich, Marc Walter, et al.
Journal of Substance Abuse Treatment (2021) Vol. 138, pp. 108717-108717
Open Access | Times Cited: 33
Substance use and spine density: a systematic review and meta-analysis of preclinical studies
Henrique Nunes Pereira Oliva, Tiago Paiva Prudente, Eric J. Nunes, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 4
Deep Brain Stimulation for Methamphetamine Use Disorder: Perioperative Neuropsychiatric and Other Medical Considerations
Luke J. Weisbrod, André Schmidt, Jody Tanabe, et al.
Journal of Neuropsychiatry (2025)
Closed Access
Social identity differentiation predicts commitment to sobriety and wellbeing in residents of therapeutic communities
Genevieve A. Dingle, Catherine Haslam, David Best, et al.
Social Science & Medicine (2019) Vol. 237, pp. 112459-112459
Open Access | Times Cited: 37
Psychological treatment for methamphetamine use and associated psychiatric symptom outcomes: A systematic review
Alexandra M. Stuart, Amanda Baker, Alexandra M. J. Denham, et al.
Journal of Substance Abuse Treatment (2019) Vol. 109, pp. 61-79
Open Access | Times Cited: 36
Psychosocial Interventions for Amphetamine Type Stimulant Use Disorder: An Overview of Systematic Reviews
Mai Thi Ngoc Tran, Quang Hung Luong, Giang Lê Minh, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 30
Prescription psychostimulants for the treatment of amphetamine‐type stimulant use disorder: A systematic review and meta‐analysis of randomized placebo‐controlled trials
Heidar Sharafi, Hamzah Bakouni, Christina McAnulty, et al.
Addiction (2023) Vol. 119, Iss. 2, pp. 211-224
Open Access | Times Cited: 12
Molecular Mechanisms of Amphetamines
Maarten E. A. Reith, Margaret E. Gnegy
Handbook of experimental pharmacology (2019), pp. 265-297
Closed Access | Times Cited: 34
Hospitalization outcomes of people who use drugs: One size does not fit all
Elisabeth A. Merchant, Deirdre Burke, Leah C. Shaw, et al.
Journal of Substance Abuse Treatment (2020) Vol. 112, pp. 23-28
Open Access | Times Cited: 31
Impact of Substance Use Disorder Pharmacotherapy on Executive Function: A Narrative Review
Kevin Butler, Bernard Le Foll
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 27
Pharmacotherapeutic strategies for methamphetamine use disorder: mind the subgroups
Edna Soares, Frederico C. Pereira
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 18, pp. 2273-2293
Closed Access | Times Cited: 26
Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials
Hamzah Bakouni, Heidar Sharafi, Arash Bahremand, et al.
Drug and Alcohol Dependence (2023) Vol. 253, pp. 111018-111018
Closed Access | Times Cited: 8
Research progress of berberine mediated photodynamic therapy (Review)
Yawen An, Hongtao Jin, Bo Yuan, et al.
Oncology Letters (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 19
Unveiling the Crucial Role of Chemical Enhancement in the SERS Analysis of Amphetamine–Metal Interactions on Gold and Silver Surfaces: Importance of Selective Amplification of the Narrow Interval of Vibrational Modes
Valerie Smeliková, Ivan Kopal, M. Člupek, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 14, pp. 5416-5427
Open Access | Times Cited: 2
Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder
Keith G. Heinzerling, Marisa Briones, April D. Thames, et al.
Journal of Neuroimmune Pharmacology (2019) Vol. 15, Iss. 2, pp. 238-248
Open Access | Times Cited: 22
Methamphetamine Use
Susanne A. Fogger
Journal of Addictions Nursing (2019) Vol. 30, Iss. 3, pp. 219-223
Closed Access | Times Cited: 20
Methamphetamine use drives decreases in viral suppression for people living with HIV released from a large municipal jail: Results of the LINK LA clinical trial
David Goodman‐Meza, Steven Shoptaw, Robert E. Weiss, et al.
Drug and Alcohol Dependence (2019) Vol. 202, pp. 178-184
Open Access | Times Cited: 18
The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder
Nazanin Aryan, Hamid Reza Banafshe, Vahid Farnia, et al.
Substance Abuse Treatment Prevention and Policy (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Stereoselective Bupropion Hydroxylation by Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase Genetic Variants
Pan‐Fen Wang, Alicia Neiner, Evan D. Kharasch
Drug Metabolism and Disposition (2020) Vol. 48, Iss. 6, pp. 438-445
Open Access | Times Cited: 15
The Use of Naltrexone in Dermatology. Current Evidence and Future Directions
Mariusz Sikora, Adriana Rakowska, Małgorzata Olszewska, et al.
Current Drug Targets (2019) Vol. 20, Iss. 10, pp. 1058-1067
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top